Program Schedule

Pigmented Mold Endocarditis Case Series and Review of the Literature

Session: Poster Abstract Session: Fungal Infections
Saturday, October 11, 2014
Room: The Pennsylvania Convention Center: IDExpo Hall BC
  • ricardo-LaHoz-42x84-IDWeek_rev3.pdf (274.2 kB)
  • Background:

    Pigmented mold endocarditis (PME) is an uncommon infection. Despite aggressive surgical and antifungal treatment, mortality remains high. A better understanding of the epidemiology and treatment of PME is needed.


    We identified PME cases from the University of Alabama at Birmingham (UAB) mycology laboratory from 1994-2012 and queried MEDLINE from 1968-2012.   Cases that met the Modified Duke Criteria for definite or possible IE were included. Cases in which PME was the result of disseminated infection in immunocompromised hosts were excluded. Demographics, clinical data, treatment and outcomes were extracted.


    A total of 44 cases (3 from UAB, and 41 from MEDLINE) were identified and included in the analysis. Mean age was 51.7 years; 30 (68%) were males. 24 (55%) were classified as PVE, 13 (30%) NVE and 5 (11%) as cardiac device infective endocarditis. The most common predisposing factor identified was a prior cardiac procedure (32/44); the median time from the procedure was 113 days. Other predisposing factors such as solid organ transplantation (31%), stem cell transplantation (15%), chronic intravenous access (23%), IVDA (15%) and HIV (8%) were prevalent in the NVE subgroup but otherwise uncommon. 30/44 had fever, and 21/44 had an audible murmur. An embolic event prior to diagnosis was common (28/44); mean events 1.6. The most common fungi were: Scedosporium apiospermum 13/44, Phialemonium curvatum 5/44 and Exophiala dermatitidis 4/44. Two of 7 and 1 of 4 isolates had high MIC’s to amphotericin B and voriconazole, respectively. Echocardiography was performed in 31 of 44 patients; it identified vegetations in 23/31, valvular regurgitation in 7/31 and an intra-cardiac mass in 5/31. Blood cultures were positive in 20 (54%) of 37 cases. The crude survival was 32% (14/44); 25% (1/4) in the medical management and 41% (12/29) in the combined medical and surgical management subgroups. Recurrence was common (10/44).


    PME is a rare disease, but it should be considered in the differential diagnosis of culture negative PVE and culture negative NVE in immunocompromised hosts, those with chronic venous access or IVDA. Lack of fever, multiple embolic events, large vegetations and positive blood cultures could be clues to the diagnosis. Mortality in PME is high and recurrence is common.

    Ricardo La Hoz, MD, Section on Infectious Diseases, Wake Forest University, Winston-Salem, NC, Milner Staub, MD, Department of Medicine, University of Washington, Seattle, WA, Stephen Moser, PhD, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, John Baddley, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL and Peter Pappas, MD, Division of Infectious Disease, University of Alabama at Birmingham, Birmingham, AL


    R. La Hoz, None

    M. Staub, None

    S. Moser, None

    J. Baddley, Merck: Consultant, Consulting fee
    Astellas: Scientific Advisor, Consulting fee
    Pfizer: Data review committee, Consulting fee

    P. Pappas, None

    See more of: Fungal Infections
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, All Rights Reserved.

    Follow IDWeek